Loading Events
Find Events

Event Views Navigation

Upcoming Events › Grant

Events List Navigation

September 2018

Cycle 1: NIH Small Business Grants

September 5

DUE DATE: SEPTEMBER 5, 2018

Small Business Innovation Research (SBIR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III.

Small Business Technology Transfer (STTR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III.

Find out more »

Cycle 1: NIH R41, R42, R43, R44, U43, U44

September 5

 

DUE DATE: SEPTEMBER 5, 2018

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed): The purpose of this funding opportunity announcement (FOA) is to support the development of novel tools and technologies through the Small Business Innovation Research (SBIR) program to advance the field of neuroscience research. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed): The purpose of this funding opportunity announcement (FOA) is to support the development of novel tools and technologies through the Small Business Technology Transfer (STTR) program to advance the field of neuroscience research. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »
October 2018

Global Brain and Nervous System Disorders Research Across the Lifespan (R01)

October 8

Sponsor: National Institutes of Health (multiple Institutes)
LOI Due Date: October 8, 2018
Application Due Date: November 7, 2018
Award: Research Project Grant. Budget not limited but must reflect actual cost of the project. Applicant may request up to 5 years.

Find out more »

Global Brain and Nervous System Disorders Research Across the Lifespan (R21) (PAR-14-331)

October 8

Sponsor: National Institutes of Health (multiple Institutes)
LOI Due Date: October 8, 2018
Application Due Date: November 7, 2018
Award: Application budgets are limited to $125,000 per year in direct costs, but must reflect the actual needs of the proposed project.

Find out more »
January 2019

ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

January 1, 2019

Sponsor: International Rett Syndrome Foundation (IRSF)
Due Date: Applications accepted on a rolling basis
Award: Up to $600,000 over two years

Find out more »

The Biomarkers Consortium

January 1, 2019

Sponsor: Foundation for the National Institutes of Health
Due Date: Rolling basis
Award: If a project idea is approved for further development and implementation, the Foundation for the National Institutes of Health will seek funding to support the resulting project and manage its execution.

Find out more »

Cycle 2: NIH Small Business Grant

January 5, 2019

DUE DATE: January 5, 2019

Small Business Innovation Research (SBIR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III.

Small Business Technology Transfer (STTR): These programs congressionally require eligible governmental agencies to set aside a percentage of their extramural budget so that domestic small businesses can engage in R&D that has a strong potential for technology commercialization. Total costs for Phase I and Phase II usually do not exceed $1,150,000; no funding is provided for Phase III.

Find out more »

Cycle 2: NIH R41, R42, R43, R44, U43, U44

January 5, 2019

DUE DATE: JANUARY 5, 2019

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed): The purpose of this funding opportunity announcement (FOA) is to support the development of novel tools and technologies through the Small Business Innovation Research (SBIR) program to advance the field of neuroscience research. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed): The purpose of this funding opportunity announcement (FOA) is to support the development of novel tools and technologies through the Small Business Technology Transfer (STTR) program to advance the field of neuroscience research. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »
+ Export Events